Results: 13

Supervivencia de pacientes con cáncer de pulmón de células no pequeñas en estadios avanzados. Matanzas
Survival of patients with non-small cells lung cancer in advanced stages. Matanzas

Rev. medica electron; 43 (1), 2021
RESUMEN Introducción: el cáncer de pulmón de células no pequeñas en estadios avanzados tiene una alta incidencia y mortalidad. Los tratamientos que se emplean son la quimioterapia, la radioterapia, las terapias dirigidas y la inmunoterapia. Es preferible que los tratamientos se realicen en el marco...

Respuesta al tratamiento con poliquimioterapia en pacientes con carcinoma no microcítico

Rev. cuba. med; 59 (2), 2020
Introducción: El cáncer de pulmón constituye una de las principales causas de muerte en Cuba. La mayoría de los enfermos acuden al servicio de salud en etapa avanzada de la enfermedad, la poliquimioterapia es uno de los tratamientos utilizados. Objetivos: Evaluar la respuesta al tratamiento con ci...

Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil

J. bras. pneumol; 46 (1), 2020
ABSTRACT Objective: To describe the morbidity, mortality, and rate of complete resection associated with robotic surgery for the treatment of non-small cell lung cancer in Brazil, as well as to report the rates of overall survival and disease-free survival in patients so treated. Methods: This was a re...

Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer

Clinics; 75 (), 2020
Many researchers have shown that pretreatment plasma fibrinogen levels are closely correlated with the prognosis of patients with lung cancer (LC). In this study, we thus performed a meta-analysis to systematically assess the prognostic value of pretreatment plasma fibrinogen levels in LC patients. A com...

La inmunoterapia una alternativa terapéutica en ancianos con cáncer de pulmón de células no pequeñas

Rev. medica electron; 41 (5), 2019
RESUMEN El cáncer es un problema prioritario de salud pública en el mundo. En Cuba constituye la segunda causa de muerte en la mayoría de grupos de edades y fundamentalmente en la población mayor de 60 años. El objetivo fue evaluar el impacto de la inmunoterapia como una alternativa terapéutica que...

Characteristics of non-small cell lung cancer: differences by sex and hormonal status in a Mexican population

Salud pública Méx; 61 (3), 2019
Abstract: Objective: To analyze the differences in the clinico-pathological and molecular characteristics of non-small cell lung cancer (NSCLC) as well as the clinical outcome of patients by sex and hormonal status. Materials and methods: We performed a retrospective study among 1 104 NSCLC patients....

Proportional weight loss in six months as a risk factor for mortality in stage IV non-small cell lung cancer

J. bras. pneumol; 44 (6), 2018
ABSTRACT Objective: To evaluate different weight loss (WL) cut-off points as prognostic markers of 3-month survival after diagnosis of stage IV non-small cell lung cancer (NSCLC). Methods: This was a prospective study involving 104 patients with metastatic (stage IV) NSCLC who were admitted to a cancer...

Smoking cessation before initiation of chemotherapy in metastatic non-small cell lung cancer: influence on prognosis

J. bras. pneumol; 44 (5), 2018

Response to cytotoxic chemotherapy and overall survival in non-small cell lung cancer patients with positive or negative ERCC1 expression

J. bras. pneumol; 44 (3), 2018

Survival in a cohort of patients with lung cancer: the role of age and gender in prognosis

J. bras. pneumol; 43 (6), 2017
ABSTRACT Objective: To determine the demographic and clinical characteristics of patients with non-small cell lung cancer (NSCLC), as well as their disease course, by age group and gender. Methods: This was a retrospective cohort study of patients diagnosed with NSCLC from 2000 to 2012 and followed unt...